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Abstract 
The present master thesis describes and analyzes the system of medicinal 
product’s pricing regulation in the Czech Republic after the year 1989. The aim 
is to execute an analysis of the current legal regulation in the context of previous 
regulation, of particular phases of the process of regulation of medicinal product’s 
prices and to provide a summary of the principles and recommendations as well 
as to attempt a proposition of future development possibilities. The thesis focuses 
on Czech legal regulation, decision-making by the judicial bodies, public bodies’ 
activity, as well as on European legislative and jurisdiction. The thesis is divided into 
five chapters. 
The first chapter involves the system of pricing and reimbursement regulation 
of medicinal products into pharmaceutic legislation. 
The second chapter is divided into two sub-chapters. The first presents 
the current legal regulation of pricing and reimbursement regulation of medicinal 
products in the context of international legislation, European legislation and European 
jurisdiction, as well as domestic legislation. The second chapter also considers public 
bodies – the Ministry of Health of the Czech Republic and the State Institute for Drug 
Control – and their activity regarding this regulation. 
The third chapter is divided into several sub-chapters. The first of them 
addresses the term pricing regulation on the general economical level. In the next, terms 
medical product and associated terms are defined. Moreover, there is described 
the process of introduction of a medicinal product to the market – process of registration 
and stipulation of price and reimbursement. The third sub-chapter describes the pricing 
regulation of medicinal products and basic principles of this regulation – official price 
stipulation in terms of maximal price. In the fourth sub-chapter, there is covered 
the history of pricing regulation of medicinal products after the year 1989, when 
the regulation was executed by the regulation activity of the Ministry of Finance up 
until the year 2007. The fifth sub-chapter analyzes the current system valid since 
the year 2008, when the prices were established by the normative activity of the State 
Institute for Drug Control in individual administrative proceedings. At this point, there 
 are presented Four phases of the process of regulated price stipulation – the price 
constituent, means of pricing regulation, range of medicinal products that are affected 
by the regulation, and a procedure in the realms of administrative proceeding 
on a maximal price stipulation. In the conclusion of the third chapter, approaches 
to a pricing regulation of medical products in some other European countries are stated. 
In the fourth chapter, the thesis focuses on the question of public bodies 
functioning forms in the field of setting up maximum prices and reimbursement levels, 
more specifically, it focuses on pricing decision, pricing regulation, individual 
administrative proceeding and measure of a general scope. 
Fifth chapter presents notes on application of subjective public rights 
of the participants of proceedings on pricing stipulation and reimbursement of medicinal 
products with regards on Czech jurisdiction. 
In the conclusion of the thesis, there is stated that the system of pricing 
regulation of medicinal products used in the Czech Republic up until the endo 
of the year 2007 was changed with regards to the European law and jurisdiction 
by the jurisdiction of the Constitutional Court of the Czech Republic. The current legal 
regulation of setting up the prices is bound by the legislation of the Ministry of Health 
of the Czech Republic and by the regulations given by the Act on General Health 
Insurance. The basic method is a pricing reference to the countries of the European 
Union. The central point of the process are individual administrative proceedings, 
the central principle is the transparency of the whole process. As a problematic aspect 
is considered the inappropriate hierarchy of the basic legislation, that stipulates 
the pricing regulation. It is suggested to unify the legal force of these regulations, 
shortening of the time periods and a simplification of individual proceedings. We can 
find here a notification of strengthening of the administrative proceeding participants’ 
position and other findings resulting from the jurisdiction. The thesis concludes that 
the pricing and reimbursement regulation of medicinal products is settled 
in the individual administrative proceedings and it is not possible to expect any main 
change of concept in a near future. The main step that solves the complex problematics 
should pass an independent act of pricing and reimbursement of medicinal products. 
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